4.8 Article

Nrf2 negatively regulates STING indicating a link between antiviral sensing and metabolic reprogramming

Journal

NATURE COMMUNICATIONS
Volume 9, Issue -, Pages -

Publisher

NATURE RESEARCH
DOI: 10.1038/s41467-018-05861-7

Keywords

-

Funding

  1. Horslevsfonden
  2. Agnes and Poul Friis Fond
  3. Brdr. Hartmanns fond
  4. Oda og Hans Svenningsens Fond
  5. Augustinus Fonden
  6. Hede Nielsens Fond
  7. Riisfortfonden
  8. Dagmar Marshalls Fond
  9. Magda Sofie og Aase Lutz's mindelegat Fond
  10. Tomrermester Jorgen Holm og hustru Elisa F. Hansens indelegat Fond
  11. Fabrikant Einar Willumsens mindelegat Fond
  12. Laege Sofus Carl Emil Friis og Hustru Olga Doris Friis Legat
  13. Sapere Aude II Grant from the Independent Research Foundation Denmark [6110-00600B]
  14. Carlsbergfonden International Research Fellowship
  15. Lundbeck postdoctoral fellowship
  16. Lundbeck PhD fellowship
  17. Danish Research Council
  18. Department of Health Sciences at Aarhus university

Ask authors/readers for more resources

The transcription factor Nrf2 is a critical regulator of inflammatory responses. If and how Nrf2 also affects cytosolic nucleic acid sensing is currently unknown. Here we identify Nrf2 as an important negative regulator of STING and suggest a link between metabolic reprogramming and antiviral cytosolic DNA sensing in human cells. Here, Nrf2 activation decreases STING expression and responsiveness to STING agonists while increasing susceptibility to infection with DNA viruses. Mechanistically, Nrf2 regulates STING expression by decreasing STING mRNA stability. Repression of STING by Nrf2 occurs in metabolically reprogrammed cells following TLR4/7 engagement, and is inducible by a cell-permeable derivative of the TCA-cycle-derived metabolite itaconate (4-octyl-itaconate, 4-OI). Additionally, engagement of this pathway by 4-OI or the Nrf2 inducer sulforaphane is sufficient to repress STING expression and type I IFN production in cells from patients with STING-dependent interferonopathies. We propose Nrf2 inducers as a future treatment option in STING-dependent inflammatory diseases.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available